Search

everythinglearnresearchcommunity

for

Search:↓

Microneedle-assisted therapy with human basic fibroblast growth factor significantly regrew hair in patients with hair loss.

People with androgenetic alopecia are more likely to have metabolic syndrome.

Post-finasteride syndrome's existence is uncertain; more research needed.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

New niosomal formulation effectively delivers aminexil through rat skin.

Intradermal injections improve hair density and thickness better, while derma roller is more convenient.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Alopecia significantly impacts mental health and quality of life, requiring psychological support.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Bariatric surgery improves health but often causes hair loss and vitamin deficiency.

Alopecia areata may be linked to hearing problems, so patients should monitor their hearing.

High levels of ceruloplasmin might indicate more severe toenail fungus.

People with hidradenitis suppurativa are more likely to have bipolar disorder than those with psoriasis or without skin conditions.

Higher IL-17A levels indicate more severe alopecia areata.

Hair analysis can detect cocaine use but doesn't accurately show the amount or timing of use.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Many people with alopecia experience high levels of social anxiety, anxiety, and depression, and while wigs can boost confidence, they may also cause anxiety.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Juvéderm fillers effectively reduce wrinkles for up to 21 months with less filler needed for repeat treatments.

Extramammary Paget disease can spread deeply into tissues, reaching up to 3.6 mm.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Reflectance confocal microscopy can help tell apart scarring from non-scarring hair loss.